BioSpace News Archive

Business

Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer

Envision Pharma Group (Envision) has appointed Dr. Jennifer Costello, PharmD, BCPS, CMPP, to the role of Chief Medical Officer.

May 4, 2023
·
3 min read
Business

Bausch Health Announces First-Quarter 2023 Results

Bausch Health Companies Inc. today announced its first-quarter 2023 financial results.

May 4, 2023
·
39 min read
Pharm Country

Henry Schein Signs Definitive Agreement to Acquire S.I.N. Implant System

Henry Schein, Inc. announced an agreement to acquire S.I.N. Implant System, one of Brazil’s leading manufacturers of dental implants, pending regulatory approval.

May 4, 2023
·
10 min read
Business

Zoetis Announces First Quarter 2023 Results

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2023 and maintained its guidance for full year 2023.

May 4, 2023
·
24 min read
FDA

FoundationOne®Liquid CDx Receives FDA-Approval as a Companion Diagnostic for EXKIVITY® (mobocertinib) to Identify Patients with EGFR Exon 20 Insertion Mutations in Advanced Non-Small Cell Lung Cancer

Foundation Medicine, Inc., a leader in molecular profiling for cancer, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for EXKIVITY® (mobocertinib).

May 4, 2023
·
11 min read
Biotech Bay

CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV)

CHMP Adopts Positive Opinion Recommending Hepcludex ® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV).

May 4, 2023
·
6 min read
Business

Bruker Reports First Quarter 2023 Financial Results

Bruker Corporation quarter ended March 31, 2023.

May 4, 2023
·
20 min read
Business

BeiGene Reports First Quarter 2023 Financial Results and Corporate Developments

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results for the first quarter 2023, recent business highlights, and upcoming milestones.

May 4, 2023
·
22 min read
Pharm Country

SIGA Declares Special Cash Dividend of $0.45 Per Share

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, announced that the Board of Directors declared a special cash dividend of $0.45 per share on the common stock of the Company.

May 4, 2023
·
6 min read
Business

Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, today reported operational highlights and financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
16 min read